Heterodox
[unable to retrieve full-text content]Explanation: The 340B Drug Pricing Program was designed to help patients access more affordable medicines. Since 1992 manufacturers have provided billions of dollars in steep discounts on outpatient medicines to safety-net clinics and qualifying hospitals expecting that those entities would use the savings to ensure vulnerable patients have access to needed medicines. But the 340B […] The post The Minnesota 340B Report Is Out appeared first on...
Read More »